# Comment on: Lee J.Z.C. et al. Case report: Hepatocellular carcinoma in a patient with Pyridoxamine 5-phosphate oxidase (PNPO) deficiency undergoing pyridoxal 5-phosphate (PLP) treatment. Mol Genet Metab Rep. 2025;9;43:101224

**Authors:** P. De Liso, R. Webster, B. Plecko, F. Vigevano

PMC · DOI: 10.1016/j.ymgmr.2025.101248 · Molecular Genetics and Metabolism Reports · 2025-08-26

## Full-text entities

- **Diseases:** Hepatocellular carcinoma (MESH:D006528), Pyridoxamine 5-phosphate oxidase (PNPO) deficiency (MESH:C566449)
- **Chemicals:** PLP (MESH:D011732)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12861739/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12861739/full.md

---
Source: https://tomesphere.com/paper/PMC12861739